Amplification, overexpression, and mutations of EGFR and PDGFRA are among the most common genetic aberrations of receptor tyrosine kinases in GBM occurring in 57.4% and 13.1% of patients, respectively (Brennan et al, 2013). This evidence concerns the gene EGFR and glioblastoma.